A phase I and pharmacokinetic (PK) study of the novel mushroom-derived cytotoxin, MGI114, in patients with advanced cancer

被引：0
|
作者：
Eckhardt, SG
Baker, SD
Moczygemba, J
MacDonald, JR
Smith, S
Von Hoff, DD
Rowinsky, EK
机构：
[1] Canc Therapy & Res Ctr, San Antonio, TX 78229 USA
[2] MGI Pharma, Minnetonka, MN USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
471
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [21] Phase I and pharmacokinetic study of vatalanib plus capecitabine in patients with advanced cancer
    Richard L. Schilsky
    David Geary
    Linda Skoog
    Apurva A. Desai
    Joyce Valickas
    Bee-Lian Chen
    Eric Masson
    Dirk Laurent
    Cynthia Pendowski
    Everett E. Vokes
    Mark J. Ratain
    Targeted Oncology, 2008, 3 : 3 - 11
  • [22] A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers
    Bhargava, P
    Marshall, JL
    Dahut, W
    Rizvi, N
    Trocky, N
    Williams, JI
    Hait, H
    Song, S
    Holroyd, KJ
    Hawkins, MJ
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 3912 - 3919
  • [23] Analysis of a phase I pharmacokinetic (PK)/food effect study of AT-101 in patients with advanced solid tumors
    Pitot, H. C.
    Mould, D.
    Maleski, J.
    Leopold, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Phase I pharmacokinetic (PK) study of daily imatinib in combination with docetaxel for patients with advanced solid tumors.
    Chatta, GS
    Fakih, M
    Ramalingam, S
    Belani, CP
    Ramanathan, RK
    Zamboni, N
    Friedland, D
    Lis, D
    Tutchko, S
    Egorin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 138S - 138S
  • [25] Phase I and pharmacokinetic (PK) study of dasatinib (D) and cetuximab (C) in patients (pts) with advanced solid malignancies
    Feinstein, T. M.
    Agrawal, S.
    Stoller, R. G.
    Egorin, M. J.
    Argiris, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancer
    Danny Rischin
    Lorraine K. Webster
    Michael J. Millward
    Guy C. Toner
    Sumith Nawaratne
    Vinod Ganju
    Prudence Francis
    James F. Bishop
    Investigational New Drugs, 1999, 17 : 73 - 80
  • [27] A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancer
    Rischin, D
    Webster, LK
    Millward, MJ
    Toner, GC
    Nawaratne, S
    Ganju, V
    Francis, P
    Bishop, JF
    INVESTIGATIONAL NEW DRUGS, 1999, 17 (01) : 73 - 80
  • [28] A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer
    Meropol, NJ
    Rustum, YM
    Petrelli, NJ
    RodriguezBigas, M
    Frank, C
    Ho, DH
    Kurowski, M
    Creaven, PJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (06) : 581 - 586
  • [29] A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancer
    Dumez, Herlinde
    Gall, Helen
    Capdeville, Renaud
    Dutreix, Catherine
    van Oosterom, Allan T.
    Giaccone, Giuseppe
    ANTI-CANCER DRUGS, 2007, 18 (02) : 219 - 225
  • [30] PHASE-I PHARMACOKINETIC STUDY OF THE METHOTREXATE ANALOG, TRIMETREXATE, IN PATIENTS WITH ADVANCED CANCER
    MORRIS, RG
    REECE, PA
    BISHOP, JF
    OLVER, IN
    RAGHAVAN, D
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (03): : 124 - 124
12345